Withdrawn
Regorafenib and sunitinib for treating advanced gastrointestinal stromal tumours
2 January 2024
Condition
Cancer
Gastrointestinal tract
Published on 04 Jan 2022
Last Updated on 02 Jan 2024
Regorafenib and sunitinib for treating advanced gastrointestinal stromal tumours Guidance is outdated and has been withdrawn on 2 Jan 2024.
The Plain English Summary (PES) has been updated on 2 Jan 2024.
